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Abstract  
Objective: Emotion regulation and emotional body language (EBL) recognition 
represent two fundamental components of emotional processing that have recently seen a 
considerable surge in research interest, in part due to the role they play in optimising 
mental health.  This appears to be particularly true for clinical conditions that can 
profoundly affect emotional functioning. Among these is Huntington’s disease (HD), a 
neurodegenerative disorder that is associated with several psychological difficulties and 
cognitive impairments, including well-established deficits in facial emotion recognition. 
However, although the theoretical case for impairments is strong, the current evidence in 
HD on other components such as emotion regulation and EBL recognition is sparse.   
Method: In this study, it was hypothesised that emotion regulation and recognition 
of EBL are impaired in people with symptomatic HD, and that these impairments 
significantly and positively correlate with each other. A between-subjects design was 
adopted to compare 13 people with symptomatic HD with 12 non-affected controls 
matched for age and education. 
Results: The results showed that emotion regulation and EBL recognition were 
significantly impaired in individuals with HD. Moreover, a significant positive correlation 
was observed between facial and EBL recognition impairments, while EBL performance 
was negatively related to the disease stage. However, emotion regulation and recognition 
performances were not significantly correlated.  
Conclusions: This investigation represents the first evidence of a deficit of emotion 
regulation and EBL recognition in individuals with HD. The clinical implications of these 
findings are explored, and indications for future research are proposed. 
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Introduction  
In the past few decades psychological research into human emotions has seen a 
surge of interest, especially due to the comprehensive conceptualisation of constructs such 
as emotional intelligence. Emotional intelligence is  defined as the set of cognitive 
processes that allows the accurate expression and appraisal of emotions in others and the 
self (Goleman, 1995; Salovey & Mayer, 1990). In particular, the identification, 
understanding, facilitation, and management of emotions have been recognised as the four 
fundamental areas required for the successful processing of emotions. Within this 
framework, a pivotal role in social and affective functioning is played by emotion 
recognition and emotion regulation (Ochsner, 2009).  
Emotion recognition can be defined as the process of correctly perceiving and 
identifying emotions in other people, as well as in artificial representations such as 
drawings or music  (Mayer, Caruso, & Salovey, 1999). Historically, the most researched 
medium of emotion recognition is whole facial expression, such as pictures of faces of 
actors expressing basic emotions such as anger or fear (Henley et al., 2012). However, 
emotion recognition is a process mediated by a number of different features other than 
facial clues, and recognition via eyes, voices, and body language have also been 
investigated (Baron-Cohen, Wheelwright, Hill, Raste, & Plumb, 2001; Beatrice de Gelder & 
Van den Stock, 2011; Lima, Castro, & Scott, 2013). The latter medium in particular is 
gaining increased attention (de Gelder, 2006; Van den Stock, Righart, & de Gelder, 2007), 
since emotional body language (EBL) recognition has so far been neglected, despite being 
deeply involved in fundamental social cognitive skills such as empathy and decision-
making (de Gelder & Hortensius, 2014). 
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Emotion regulation is defined as the “processes by which individuals influence 
which emotions they have, when they have them, and how they experience and express 
these emotions” (Gross, 1998; p. 275). More specifically, it involves the processes of 
selecting and modifying potential emotional situations, deploying attention, changing one’s 
perspectives on emotions, and modulating emotional responses (Gross, 1998; 2015). In the 
last 20 years this area  has seen a considerable increase in interest due to the recognition 
of its importance for psychological resilience and mental health (Aldao, Nolen-Hoeksema, 
& Schweizer, 2010; Ghorbani, Khosravani, Sharifi Bastan, & Jamaati Ardakani, 2017; Gross 
& Muñoz, 1995; van der Meer, van Duijn, Giltay, & Tibben, 2015).  
Based on the theory of emotional intelligence, emotion recognition and emotion 
regulation are deeply interconnected processes, since emotions need to be correctly 
recognised before they can be regulated (Izard et al., 2001; Mayer, 2001; Salovey & Mayer, 
1989; Yoo, Matsumoto, & LeRoux, 2006). This is also supported by evidence on the neural 
bases of both processes, which involve similar subcortical structures such as the limbic 
system and the basal ganglia (Gross, 2013). Not surprisingly, deficits of emotional 
processing are observed in many neurodegenerative conditions that involve damage to 
those structures, such as Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, and – 
with a particularly well-established impact on emotion recognition skills – Huntington’s 
disease (Löffler, Radke, Morawetz, & Derntl, 2015).  
Huntington’s disease (HD) is a genetic neurodegenerative disorder whose typical 
symptoms include involuntary movements (chorea), cognitive deterioration, and 
considerable psychological problems (Novak & Tabrizi, 2005). Its prevalence across North 
America, Europe, and Australia is 5.7 people  per 100,000 (Pringsheim et al., 2012). The 
transmission mechanism is autosomal-dominant, meaning that affected individuals’ 
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children have a 50% probability of inheriting the gene, and genetic testing is available to 
ascertain gene status (in which case the term ‘presymptomatic’ is used). The onset is 
usually around age 40, and disease progression can be divided into five stages, starting 
with mild motor symptoms, cognitive impairment and relative independent functioning 
(Stage I), and ending with a need for full-time care due to severe motor impairment and 
dementia (Stage V; Shoulson & Fahn, 1979).  
One of HD’s most frequently observed cognitive impairments is a deficit of emotion 
recognition, particularly negative emotions such as anger, fear, and disgust (Bates, Tabrizi, 
& Jones, 2014). However, while the evidence on this set of impairments is well established, 
it has been traditionally investigated only through tests based on facial expressions, with 
very few studies based on different stimuli such as emotional body language (see Henley et 
al., 2012 for a review). In fact, to our knowledge only two studies have investigated EBL in 
HD, showing preliminary evidence that a deficit of EBL recognition can also be part of the 
manifestations of the disease (de Gelder et al., 2008), although it may not be observed in 
presymptomatic individuals (Aviezer et al., 2009).  
In addition to the sparseness of evidence on EBL, very little is also known about 
emotion regulation in HD. Indeed, a recent review (Löffler et al., 2015) identified only one 
study where this is specifically addressed and which concluded no differences between 
people with symptomatic HD and healthy controls (Croft, McKernan, Gray, Churchyard, & 
Georgiou-Karistianis, 2014). However, the measure adopted by this study – the Emotion 
Regulation Questionnaire (ERQ; Gross et al., 2003) – only assesses the use of two 
regulatory strategies (suppression and reappraisal), and does not allow for the exploration 
of any other specific components of emotion regulation, such as impulse control or 
emotional awareness.  
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As mentioned previously, emotion recognition (both facial and EBL) and emotion 
regulation are likely to influence each other (Ochsner, 2009) and play an essential role in 
the successful operation of social skills as well as psychological resilience (de Gelder & 
Hortensius, 2014; Ghorbani et al., 2017; Gross & Muñoz, 1995). Given the theoretical 
arguments for evidence of such deficits in individuals with HD, a deeper understanding of 
the extent to which the disease affects these cognitive components would allow for a 
refinement of current cognitive and behavioural approaches to care and treatment. 
Moreover, this carries the potential for shedding new light on the neural bases that 
characterise them and the relationship between cognition and neurobiology, in particular 
in relation to EBL recognition (de Gelder, 2006). Both these implications have, in turn, the 
potential to contribute to an ongoing debate which focuses on whether the current 
diagnostic criteria for HD, which are based on motor manifestations only, should also 
include early signs of cognitive impairment. (Loy & McCusker, 2013; Paulsen, 2011; 
Reilmann, Leavitt, & Ross, 2014) 
Consequently, the aim of this study was to investigate the hypothesis that both 
facial and EBL recognition and emotion regulation are impaired in individuals affected by 
symptomatic Huntington’s disease, and that such impairments show a significant 
relationship with one another. The study design included a comparison with non-affected 
matched controls and the use of more comprehensive tests of emotion recognition and 
regulation. More specifically, the following hypotheses were formulated: a) People with HD 
were predicted to report significantly more emotion regulation difficulties than the control 
group when assessed on a number of different emotion regulation components; b) emotion 
recognition was predicted to be significantly impaired in people with HD compared to the 
controls on both facial and EBL tasks; c) a significant relationship was expected to be 
observed between emotion regulation difficulties and emotion recognition impairment. In 
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addition, due to the evidence of relationships between psychological difficulties and 
emotional processing (Cisler, Olatunji, Feldner, & Forsyth, 2010; Joorman & Gotlib, 2010; 
Martin & Dahlen, 2005), depression and anxiety measures were also included. 
Methods 
Design and participants 
This study adopted a 2-group between-subjects design with matched controls. In 
total, 25 participants took part, split across two groups (HD and Ctrl) consisting of 13 
symptomatic individuals (four male, nine female) and 12 matched non-affected controls 
(five male, seven female). The sample size of the HD group was comparable to the majority 
of studies investigating emotion recognition in HD that have been identified by a recent 
systematic review (i.e., six to 40; Henley et al., 2012). For the HD group, participation was 
limited to individuals in early to moderate stages of the disease (i.e., I-III). This was 
decided due to the difficulties in undertaking cognitive tasks that are likely to arise in the 
later stages of the condition. HD stage was screened through the Total Functional Capacity 
scale (TFC; Shoulson & Fahn, 1979). More specifically, one participant (7.7%) belonged to 
stage I, seven (53.8%) to stage II, and five (38.5%) to stage III.  
The two groups did not present any significant differences in terms of age [t(23) 
= .490, p = ns], years of education [t(23) = -1.023, p = ns], or gender [X2(1, N = 25) = .322, p 
= ns]. See Table 1 for the full demographic details.  
 
Table 1 around here please 
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The participants of the HD group were recruited with the help of the Regional Care 
Advisory Service of the Huntington’s Disease Association (HDA) in the UK. The participants 
of the Ctrl group were recruited from partners and caregivers of the participants of the HD 
group. While this may have not represented the most optimal control group due to 
potential interactions between the participants, it was considered appropriate as it 
allowed the recruitment of controls with similar demographic and social characteristics. To 
limit the risk of confounds, the partners/caregivers were not in the room when the 
patients were performing the required tasks.  
Measures 
HD severity measures  
Total Functional Capacity Scale (TFC; Shoulson & Fahn, 1979): 
The TFC is a standardised tool that assesses everyday functional capacities such as 
working, handling money, taking care of domestic chores, performing self-care tasks, and 
living independently. It is part of the larger Unified Huntington’s Disease Rating Scale 
(UHDRS; Huntington Study Group, 1996). The total score ranges from 13 (normal capacity) 
to 0 (severe disability) and its intervals can be used to determine the stage of the disease: 
13-11 = Stage I, 10-7 = Stage II, 6-3 = Stage III, 2-1 = Stage IV, 0 = Stage V. The TFC is 
characterised by excellent internal consistency (Cronbach’s α = .95) as well as high 
interrater reliability (Huntington Study Group, 1996). 
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Emotion recognition measures 
Bochum Emotional Stimulus Set (BESST; Thoma, Soria Bauser, & Suchan, 2013):  
The BESST is a validated set of 4490 emotional stimuli consisting of pictures of both 
male and female facial expressions and emotional body language (EBL). It investigates the 
recognition of six emotions (fear, disgust, happiness, sadness, surprise and anger) plus 
neutral expressions. The facial expressions are computer-generated, while the EBL stimuli 
are based on photographs of actors and actresses. All the stimuli feature multiple ethnic 
groups. For this study, 10 frontal stimuli from the BESST were randomly selected for each 
emotion and each expression modality (facial or EBL), half male and half female, to a total 
of 140 stimuli for two blocks (70 + 70). Thus, the test in this study yielded a total score out 
of 70 for each modality, as well as a sub score out of 10 for each emotion. The BESST 
reports excellent norms (Abramson, Marom, Petranker, & Aviezer, 2017), with overall high 
recognition rates for the whole corpus (83.3% for faces, 85.5% for bodies; Thoma et al., 
2013). Other measures of EBL recognition are available in the literature, such as the  
Bodily Expressive Action Stimulus Test (BEAST; de Gelder & Van den Stock, 2011). 
However, the latter only consists of the body language component and does not include 
stimuli for disgust. Therefore, as the recognition of negative emotions plays a particularly 
important role in HD (Bates, Tabrizi, & Jones, 2014),  the BESST was preferred in this study 
due to its inclusion of disgust, as well as for being currently the only test to include both 
facial and EBL stimuli within a single set.  
Emotion regulation measures 
Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004) 
The DERS is a self-report questionnaire based on 36 items rated on a 5-point Likert 
scale. It explores emotion regulation on the basis of 6 subscales: non-acceptance of 
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emotional responses, difficulties engaging in goal directed behaviour, impulse control 
difficulties, lack of emotional awareness, limited access to emotion regulation strategies, 
lack of emotional clarity. A subscore is yielded for each subscale, which can then be 
summed to create a total score out of 180 for the whole questionnaire. Higher scores 
correspond to more difficulties in emotion regulation. To our knowledge, the DERS has 
never been adopted with people affected by symptomatic HD, but it has been utilised with 
a number other clinical conditions (Fowler et al., 2014; Kökönyei, Urbán, Reinhardt, Józan, 
& Demetrovics, 2014), showing very good construct validity (Ritschel, Tone, Schoemann, & 
Lim, 2015) and internal consistency (Cronbach’s α = .93/.89 for total score/subscales Gratz 
& Roemer, 2004).  
Mood and anxiety issues measures 
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) 
The HADS is currently one of the most adopted measures of mood and anxiety 
symptoms in clinical populations and consists of a self-report questionnaire based on 14 
items rated on a 4-point scale. The outcome consists of individual scores out of 21 for both 
anxiety and depression. The HADS has been previously validated with people affected by 
HD (De Souza, Jones, & Rickards, 2010), and features good construct validity and internal 
consistency, with a Cronbach’s α = .83/.82 for anxiety/depression respectively (Bjelland, 
Dahl, Haug, & Neckelmann, 2002). The suggested cut-off point for clinical depression and 
anxiety is 8/21, which guarantees good sensitivity (anxiety/depression = .90/.83) and 
specificity (anxiety/depression = .78/.79).  
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Procedure  
In general, all the questionnaires were completed by hand by the participants 
directly. However, in case of difficulties due to motor impairments, the questions were 
read out to the participants and their responses were recorded by the first author on their 
behalf. While this approach posed a certain risk of response bias due to 
misunderstandings, it was adopted to allow the participants with more severe motor 
impairments to feel as comfortable as possible during the data collection.  In order to 
minimise the risk of bias, during recording the responses, the first author asked for 
clarifications regarding the participants’ answers whenever necessary.  
The two blocks of the BESST were administered by the first author on a 15-inch 
laptop. Each stimulus was presented singularly on a black background in an 834x834 pixel 
format along with seven emotional labels on the right corresponding to the emotions 
investigated by the test. The participants were asked to name the label corresponding to 
the presented stimulus. This seven-alternative method differed from the way the test was 
administered in the validation study (Thoma et al., 2013), which consisted of a two-
alternative forced choice task.  The seven-alternative method was considered the most 
appropriate as it has been previously adopted with the BESST (Abramson et al., 2017; 
Soria Bauser, Thoma, & Suchan, 2012). It is also included in tests which are considered the 
‘gold standard’ of facial and EBL recognition tests, , such as the Reading the Mind in the Eye 
test (RME, Baron-Cohen et al., 2001), the Bodily Expressive Action Stimulus Test (BEAST, 
de Gelder & Van den Stock, 2011), the CANTAB Emotion Recognition Task ( Sahakian & 
Owen, 1992), the Emotion Hexagon Task (Calder et al., 1996), and the original Ekman 60 
Faces Test (Ekman, Friesen, 1976). As the answers were provided verbally by the 
participants, no direct interaction was required between them and the laptop. A practice 
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session consisting of seven stimuli (one for each emotion) was administered prior to the 
beginning of each block, to allow for familiarisation with the task. The order was kept 
constant among the participants, with the face block being administered prior to the body 
language block. No time limit was set for responses. However, the participants were asked 
to perform the tasks as quickly as possible. Figure 1 illustrates examples of neutral, 
positive, and negative stimuli administered via the BESST.  
Statistical analysis 
All the statistical analyses were performed with IBM SPSS Statistics® programme 
v23 (Armonk, NY: IBM Corp). On account of the relatively small sample size, non-
parametric statistics were adopted. This is a common choice when working with small 
sample of symptomatic HD participants, and especially when investigating emotional 
processing (e.g., Croft et al., 2014; Snowden et al., 2008; Trinkler, de Langavant, & 
Bachoud-Levi, 2013). Mann-Whitney tests were performed to make comparisons between 
the two participant groups, while two-tailed Spearman’s correlations were utilised to 
investigate the relationship between the two main outcome variables. Effects sizes were 
calculated with Cohen’s d. In order to avoid loss of power due to the adoption of 
conservative corrections with a small sample size, significance levels were conventionally 
set at p = .05 with no correction for multiple comparisons. This was in line with several 
previous studies on emotion recognition in small samples of people with HD (Croft et al., 
2014; Ille, Holl, et al., 2011; Ille, Schafer, et al., 2011; Novak et al., 2012; Robotham et al., 
2011; Snowden et al., 2008; Sprengelmeyer, Schroeder, Young, & Epplen, 2006; van 
Asselen et al., 2012), as well as in other rare clinical populations (e.g., frontotemporal 
dementia; Keane, Calder, Hodges, & Young, 2002).   
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Ethics approval 
This study was reviewed and approved by the Faculty of Health and Medicine Research 
Ethics Committee at Lancaster University (ref: FHMREC15043). 
Results 
Measure reliability 
All the adopted measures generally showed good levels of reliability comparable to 
the levels reported in the literature (Bjelland et al., 2002; Gratz & Roemer, 2004). More 
specifically, high internal consistency was shown by HADS for both anxiety (Cronbach’s α 
= .808) and depression (Cronbach’s α = .805).. With regards to the BESST, the total scores 
showed high internal consistency in both the facial (Cronbach’s α = .758) and emotional 
body language (Cronbach’s α = .863) modalities. The single emotions scores generally 
showed acceptable figures, with Cronbach’s α ranging between .616 and .896. However, 
low levels were found for the fear facial score (Cronbach’s α = .567), and for both the facial 
and emotional body language scores for surprise (Cronbach’s α = .531 and .352). As for the 
DERS, high internal consistency was found throughout the whole measure, with a 
Cronbach’s α of .941 for the SUM score, and figures ranging from .763 to .855 for the 
subscales. 
Participants’ scores 
Table 2 shows the mean scores of the participants of both the HD and Ctrl groups 
for the outcome variables, and Figure 2 provides a graphical illustration of the scores. 
According to the recommended clinical cut-off for the HADS (8/21; Bjelland et al., 2002), 
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six of the participants of HD group (i.e., 46.15%) showed clinical levels of anxiety, while 
seven (i.e., 53.8%) showed clinical levels of depression. On the other hand, only three of 
the participants of the Ctrl (i.e., 25%) group showed clinical levels of anxiety, and only one 
(i.e., 8.3%) reported clinical levels of depression.  
The general results for emotion recognition showed a slightly better performance 
on the body language modality compared to the facial one in both groups. However, in this 
study the BESST constituted quite an arduous task for all the participants, as rather low 
overall recognition rates were observed for both the HD group (32.6% for faces, 40.2% for 
bodies) and the controls (45.6% for faces, 56.5% for bodies). These represented lower 
rates compared to the ones reported by the validation study (i.e., 83.3/87%; Thoma et al., 
2013), but were in line with those reported in studies that adopted the BESST with a 
multiple forced-choice paradigm (e.g., 50%; Abramson et al., 2017). In terms of specific 
emotions, in the face task the least recognised emotion in both groups was sadness (HD: 
10.8%, Ctrl: 19.2%), while the most easily identified was happiness (HD: 70%, Ctrl: 
92.5%). The results on these two emotions were in line with the findings of the validation 
study. On the other hand, in the body language modality the lowest scores were observed 
on disgust for both groups (HD: 10%, Ctrl: 17.5%), while the highest were again on 
happiness (HD: 75.4%, Ctrl: 78.3%), along with neutral stimuli (HD: 70%, Ctrl: 92.5%). 
Contrary to the facial modality, this result was opposite to the validation data, which found 
happiness body stimuli to be least recognised. 
With regard to emotion regulation difficulties, the total score (SUM) of the HD group 
was significantly higher than the available data with general adult populations (e.g., 
77/180; Ritschel et al., 2015),  meaning that considerably more emotion regulation 
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difficulties were reported by the HD participants. Instead, on average the Ctrl group scored 
rather lower (67/180) compared with the normative data.  
Group comparison analysis 
The group comparison analysis showed that the participants affected by HD had a 
significantly greater level of depression when compared to the controls (U = 27.0, z = -
2.787, p = .005); however, no significant difference was found for anxiety levels (U = 72.0, z 
= -.328, p = ns).  
With regard to emotion recognition, the overall performance of the HD group on the 
BESST was significantly poorer for both the facial (U = 16.5, z = -3.352, p < .001 and body 
language (U = 32.0, z = -2.510, p = .012) modalities. In terms of specific emotions, the facial 
modality revealed specifically greater impairments in the HD group for disgust (U = 34.5, z 
= -2.402, p = .016) and anger (U = 42.0, z = -2.082, p = .012), while the body language 
modality yielded poorer performances for fear (U = 25.0, z = -2.914, p = .004), sadness (U = 
33.0, z = -2.481, p = .013), and neutral stimuli (U = 32.0, z = -2.144, p = .012).   
In terms of emotion regulation, a significantly greater level of total difficulties 
(DERS SUM) was reported by the HD group (U = 29.5, z = -2.639, p = .008). When 
comparing the specific components of the DERS, significant differences were observed on 
impulse control difficulties (IMPULSE; U = 28.5, z = -2.730, p = .007), and lack of emotional 
clarity (CLARITY; U = 30.5, z = -2.595, p = .008).  
The effect size analysis showed a very large group effect on the overall scores for 
facial emotion recognition (d = -1.54), emotional body language recognition (d = -1.378), 
and emotion regulation (d = 1.011). Moreover, in spite of a lack of statistical significance, 
several medium to large effect sizes were observed for specific components of the outcome 
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variables, thus showing group effects at a trend level. These included limited access to 
regulation strategies (STRATEGIES; d = 1.016), difficulties in engaging in goal directed 
behaviour (DERS GOALS; d = .679), lack of emotional awareness (DERS AWARE; d = .656), 
facial recognition of happiness (d = -.491), sadness (d = -447), and surprise (d = -.769), as 
well as body language recognition of disgust (d = -.452), surprise (d = -.599), and anger (d = 
-.466). 
Correlation analysis 
In light of the significant differences observed in symptomatic individuals on the 
group comparison, a correlation analysis was carried out to explore whether the 
impairments on emotion regulation and recognition in the HD group were correlated with 
the demographic characteristics and the measures of psychological difficulties. Table 4 
illustrates Spearman’s coefficients for the correlation analysis of the HD group among the 
all the variables. The results showed that, with regard to emotion recognition, the overall 
performance for the facial modality of the BESST (BESST_F_SUM) was strongly correlated 
with the overall performance for the body language modality (BESST_B_SUM; rs = .739, p 
< .001), confirming the relationship between the two emotion recognition components. 
This was also confirmed by the observation of significant relationships across the 
modalities between the single scores for neutral stimuli (rs = .606, p = .028), disgust (rs 
= .582, p = .037), and anger (rs = .589, p = .034), as well as linear trends close to significance 
for fear (rs = .526 p = .065) and surprise (rs = .499, p = .082). In addition, the total score for 
the body language modality (BESST_B_SUM) shared a significant strong negative 
relationship with HD stage (rs = -.675, p = .011), meaning that the recognition of emotional 
body language of the participants affected by HD deteriorated in line with disease 
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progression. The total score for the facial modality (BESST_F_SUM), showed a similar trend 
towards HD stage (rs = -.533, p = .060).   
In terms of emotion regulation, the overall level of emotion regulation difficulties 
(DERS_SUM) shared a very strong positive correlation with levels of anxiety (HADS_A; rs 
= .905, p < .001), as well as a strong correlation with levels of depression (HADS_D; rs 
= .629, p = .021). In particular, the two components that were specifically impaired in the 
HD group, IMPULSE and CLARITY, were respectively related to anxiety (rs = .675, p = .011) 
and depression (rs = .717, p = .006). 
Discussion 
Overview of main findings 
This aim of this study was to investigate whether facial and EBL recognition and 
emotion regulation were impaired in people with symptomatic HD when compared to 
matched controls, and whether such impairments were significantly correlated. In 
addition, to our knowledge this was the first study with this specific population both to 
explore emotion regulation at the same time as emotion recognition and to include facial 
and EBL recognition modalities together. The results showed significant impairments in 
the HD group in emotion regulation, as well as emotion recognition in both the facial and 
EBL modality. This was in line with our initial predictions and confirmed our first two 
hypotheses.  
In terms of specific components of emotion regulation, significant differences were 
found for impulse control difficulties (DERS IMPULSE) and lack of emotional clarity (DERS 
CLARITY) in the HD group when compared to healthy controls. This appears to be 
consistent with several previous observations of impulse control and executive functioning 
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deficits in people with HD (Duff et al., 2010; Galvez et al., 2017; Gray et al., 2013; Mörkl et 
al., 2016), that are often due to the impact of the disease on prefrontal brain areas (Dogan 
et al., 2014; Gray et al., 2013) and are likely to play a pivotal role in the clarity and control 
of emotional experiences. No significant differences were observed for the remaining 
components of emotion regulation, including DERS STRATEGIES. This particular finding 
was in line with the only other study on emotion regulation in people with HD, which only 
explored the use of regulatory strategies and found no significant differences with matched 
controls (Croft et al., 2014). In addition, since no authors have previously carried out a 
comprehensive investigation of emotion regulation in HD which includes all its 
components, the significant difference on the DERS SUM observed in this study represents 
the first preliminary evidence of a general impairment of emotion regulation in this 
specific population.  
The observed impairment for facial emotion recognition adds further confirmation 
to the already well-known deficit reported in the literature (for a review, see Bates, Tabrizi, 
& Jones, 2014). Moreover, the results on the single emotion scores also confirmed the 
known specific deficit of negative emotions such as disgust and anger, even though no 
significant difference was found for the facial recognition of fear and sadness. The 
impairment on the EBL modality was partially in line with the only other study that 
investigated this construct in people with symptomatic HD and which  found a significant 
impairment in the recognition of anger and emotionally neutral instrumental stimuli, but 
no deficit for fear and sadness (de Gelder et al., 2008). Indeed, a specific impairment for 
neutral (yet not instrumental) stimuli was found in the our study too, although the 
comparisons on the single emotion scores in this study yielded almost opposite results, 
with a significant impairment for fear and sadness, but no significant deficit for anger. As 
de Gelder and colleagues (2008) did not include stimuli for happiness, surprise, and 
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disgust, it is not possible to know whether other emotions were impaired, and to what 
extent our results differ. As a consequence, the finding of our study also represents the first 
preliminary evidence of an impairment of emotional body language (EBL) recognition in 
people with symptomatic HD through a comprehensive assessment that includes both 
positive and negative emotional stimuli, as well as the first study to assess the impact of 
the disease on the recognition of disgust via body language. 
With regards to the relationship between emotion regulation and emotion 
recognition, the correlation analysis showed that the observed impairments did not 
significantly correlate. This finding was contrary to the study’s third hypothesis.  
Moreover, it was also inconsistent with what  has been previously reported in other 
clinical populations, such as in people with anorexia nervosa (Harrison et al., 2009). On the 
other hand, the overall level of emotion regulation difficulties shared a significant 
correlation with anxiety and depression. In addition, impulse control difficulties and lack of 
emotional clarity – the two emotion regulation components that were specifically impaired 
in the HD group – shared significant relationships with anxiety and depression 
respectively.  
These findings suggest that, in the HD group, anxiety and depression might have 
played a pivotal role in the operationalisation of emotion regulation. While the small 
participant number makes this impossible to test statistically through more sophisticated  
analyses,  the results  are consistent with previous reports of associations between mood 
and anxiety problems and deficits of emotion regulation (e.g., Ehring et al., 2008; Loas et 
al., 1997; for a review on anxiety, see Cisler, Olatunji, Feldner, & Forsyth, 2010), and in 
particular between impulse control and anxiety  (e.g., with Parkinson’s disease; Voon et al., 
2011), and emotional clarity and depression (Dixon-Gordon et al., 2014; Thompson, Boden, 
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& Gotlib, 2017).  Thus, the significant difference on the DERS in the HD group when 
compared to the Ctrl group may represent a reflection of the significantly higher level of 
depression reported by the symptomatic participants.  
Implications for clinical practice 
These findings have important implications for clinical practice, as emotion 
regulation deficits have the potential to disrupt people’s daily life in a large number of 
ways(Gross & Muñoz, 1995). In particular, current evidence suggests that they may cause 
issues with affective experience (e.g., a decrease in experience of positive emotions), 
cognitive functioning (e.g., lower memory performance), as well as social skills, such as  
theory of mind and communication (Gross & Award, 2002). All these issues appear to be 
even more relevant for people with symptomatic HD, as they are likely to add to (and 
potentially worsen) the affective, cognitive, and communicative impairments already 
caused by other symptoms of the condition (Eddy & Rickards, 2015; Hartelius, Jonsson, 
Rickeberg, & Laakso, 2010; Hubers et al., 2012; Paulsen, 2011; Zarotti, 2016; Zarotti, 
Simpson, & Fletcher, 2017). 
As a consequence, a more in-depth understanding of emotional processing in HD 
currently plays a pivotal role in clinical practice, since it has the potential to help revise 
current therapeutic and communicative protocols, as well as informing new ones. Indeed, 
the possibility of enhancing patients’ cognitive reserves through cognitive training 
interventions has proven to be a very promising approach to delay or control the onset of 
cognitive symptoms in neurodegenerative diseases (Papoutsi, Labuschagne, Tabrizi, & 
Stout, 2014). With regard to this, recent preliminary evidence suggests that addressing 
emotion recognition impairments at both presymptomatic and early stage HD via self-
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guided computerised cognitive training can lead to significant improvement in recognition 
accuracy (Kempnich, Wong, Georgiou-Karistianis, & Stout, 2017). In particular, the case of 
HD represents an ideal model for the exploration of this type of cognitive training, due to 
its genetic nature, the availability of predictive testing, and the consequent well-
established underlying pathological mechanisms (Papoutsi et al., 2014).  
Perhaps even more significantly, the finding that emotion regulation deficits are 
strongly related to levels of depression and disease stage may have a number of important 
clinical and therapeutic consequences. Indeed, emotion regulation strategies and 
depressive symptoms have been reported to share stable significant relationships across 
many different populations, including adolescents, adults, elderly and people with 
psychological difficulties (Berking, Wirtz, Svaldi, & Hofmann, 2014; Garnefski & Kraaij, 
2006). Moreover, evidence has identified depression as a critical factor in triggering  a 
general decrease in coping skills and resilience (Penland, Masten, Zelhart, Fournet, & 
Callahan, 2000), especially in people affected by neurodegenerative disorders (Baquero, 
2015). Considering the pivotal role played by emotion regulation strategies in the 
successful implementation of coping skills and resilience (Ghorbani et al., 2017; Gross & 
Muñoz, 1995; Hasking et al., 2010; van der Meer et al., 2015), it could be hypothesised that 
the combinations of these mechanisms may contribute to the development of a unhelpful 
circle of regulation difficulties and psychological difficulties. More specifically, suboptimal 
coping and resilience due to depression would lead to depleted emotion regulation skills, 
which would in turn contribute to higher levels of depression, in a mechanism that 
increases in severity along with disease progression.  
This hypothesis appears consistent with results from our previous investigation 
with people with premanifest HD where, despite the absence of general clinically 
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significant levels of depression or emotion regulation deficits, subclinical depressive 
symptoms were found to significantly predict early difficulties on specific components of 
emotion regulation (Zarotti, Simpson, Fletcher, Squitieri, & Migliore, 2018). As a 
consequence, addressing emotion regulation deficits along with depression in people with 
HD may open up new avenues for alternative forms of psychological intervention. Indeed, a 
growing body of evidence suggests that emotion regulation may represent a 
transdiagnostic construct in psychological difficulties (Sloan et al., 2017).  
For example, Berking and colleagues (2008) suggested that replacing parts of 
standard cognitive behavioural therapy (CBT) treatment with training in emotion 
regulation may enhance the effectiveness of CBT. In particular, the authors applied 
the Integrative Training of Emotional Competencies(ITEC; Berking 2007)28an 
intervention based on the intensive practice of a number of emotion regulation skills 
including progressive muscle and breathing relaxation, non-judgemental awareness of 
emotions, acceptance and tolerance of negative emotions, effective self-support, analysis of 
emotional cues, and quantitative and qualitative modification of emotional reactions, 
which all yielded a significant enhancement of the effects of CBT, These findings appear 
even more important for HD, as CBT currently represents one of the most adopted 
approaches to psychotherapy in this condition (Anderson et al., 2011; Ghosh & Tabrizi, 
2013; Novak & Tabrizi, 2011). Thus, the inclusion of emotion regulation as a treatment 
target in psychotherapy may yield greater beneficial effects for both people with 
presymptomatic and symptomatic HD. 
Limitations and future directions 
A number of limitations should be considered along with the results of this study. 
First, the data collection sessions, which occurred within a single day at the participants’ 
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home, proved to be challenging for some of the participants. For this reason, no cognitive 
screening was performed prior to the administration of the research materials. While it is 
recognised that this prevented a more precise understanding of the participants’ level of 
overall cognitive functioning, which would have allowed for a better clinical depiction of 
the stage of disease and cognitive performance more generally, it also allowed the 
cognitive load to remain manageable throughout the data collection. Thus, avoiding the 
risk of increased fatigue affecting the performance of the participants on the experimental 
measures was prioritised over the potential benefits of adding of a cognitive screening as a 
covariate.  
Secondly, the overarching aim of this study was to investigate whether emotion 
regulation and both facial and EBL recognition were impaired in people affected by 
symptomatic HD. As a consequence, no clinical control group was included in the design 
and this could have isolated factors specific to people with HD as opposed to other 
neurodegenerative diseases more generally. However, while this decision fitted the 
purpose of this study, it is recognised as a limitation.  
Thirdly, the generally low recognition rates on the BESST showed that the emotion 
recognition tasks were somewhat difficult for both the HD and Ctrl group as compared to 
the available normative data. This is likely due to the differences in the way the tasks were 
administered compared to the validation study (Thoma et al., 2013), which was based on a 
two-alternative forced choice task with a 3000ms limit, while the present study featured a 
seven-alternative forced choice task with no time limit. Indeed, lower recognition rates 
have also been reported when adopting the BESST with the same method as the present 
study, i.e. with tasks based on four or more alternatives (Abramson et al., 2017). In 
addition, the general better performance observed in both groups on the EBL recognition 
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component as opposed to the facial one may be due to an effect of familiarisation due the 
order of presentation of the tasks (facial first, EBL second), which was kept constant 
among the participants.  
Finally, an important caveat to be noted is the potential effect of the relatively small 
sample size, despite it being in line with most of the current studies on emotion 
recognition in HD (Bates, Tabrizi, & Jones, 2014). Indeed, the effect size analysis showed 
that most of the observed inconsistencies with the results in the previous literature in fact 
represented differences at a trend level characterised by medium to large effect sizes (d = 
-.452 – 1.016). This could be also applied to some of the results of the correlation analysis 
that were approaching significance, such as the correlation between facial emotion 
recognition and HD stage. With regard to this, it is worth noting that the sample size of the 
present study may have partially affected effect sizes, potentially making them deviate 
from the real population effect sizes farther than a larger sample. However, considering the 
current direction of the evidence available from other investigations, it seems reasonable 
to hypothesise that the effect sizes observed in this study were in fact not significantly 
affected by the sample size. Consequently, the adoption of a larger sample would yield 
significant differences on fear, sadness, and anger in line with the findings in the previous 
literature, as well as significant correlations in line with the ones that were found in this 
study. Thus, the conclusion that HD directly impacts emotion regulation should be 
considered preliminary and taken cautiously until additional evidence is obtained with 
larger samples. 
Future research should aim at further exploring emotion regulation and emotion 
recognition in larger samples of people with different stages of symptomatic HD, in order 
to obtain a better understanding of the potential relationship between these two 
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constructs. In particular, more investigations are needed on the inclusion of emotion 
regulation as treatment target in psychotherapy for people with this condition. As for 
emotional body language, other measures of EBL recognition should also be adopted with 
HD populations, in order to control for the convergent validity of the BESST and to build a 
comprehensive corpus of data similar to the one currently available for facial stimuli. In 
particular, more data are warranted on the optimal use of the BESST stimuli when based 
on a multiple-choice forced task, in order to avoid potential floor effects in participant 
performance. From this perspective, the adoption of EBL measures would benefit from the 
inclusion in large multi-centre studies, which would also allow the integration of 
comprehensive cognitive screenings.Finally, clinical control groups of people affected by 
diseases that share common symptoms with HD (e.g., people with Parkinson’s disease) 
should be included, in order to clarify the role of the different factors that may contribute 
to the development of emotion regulation and EBL recognition impairments.  
Conclusion  
This study has shed new light on emotional processing in people with symptomatic 
Huntington’s disease by providing different sources of evidence that emotion regulation 
and emotional body language (EBL) recognition are significantly impaired in this 
population, and that the latter is negatively related to the stage of disease. It also provided 
the first preliminary evidence of a significant direct correlation between deficits of facial 
and body language emotion recognition in HD, although emotion regulation and emotion 
recognition were not related.  
Altogether, these findings support the suggestion that better insight into emotion 
recognition and regulation issues in HD, along with their connections to mood and anxiety 
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disorders, would allow the development of psychological and pharmacological 
interventions that are tailored around the emotional needs of each patient. 
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Demographics of the participants. 
 HD    Ctrl   
 
 Mean SD Range  Mean  SD Range 
Age (yrs) 53.46  5.109 42-63  52.17  7.907 33-63 
Education (yrs) 12.92  2.66 11-18  14 2.594 11-18 
Diagnosis time (yrs) 5.54  1.713 3-9    
TFC score  6.92 2.139 13-0     
Note. Ctrl = control group; HD = Huntington’s disease group; SD = standard deviation; TFC = Total Functional 






Participants’ scores across the outcome variables.  
 HD Ctrl Between-group comparison Reliability 
Mean (SD) Mean (SD) U p d α 
HADS 
HADS-A 7.00 (5.80) 5.58 (2.46) 72.00 ns .318 .808 
HADS-D 8.00 (4.49) 3.00 (2.697) 27.00 .005 1.350 .805 
        
DERS 
SUM 90.92 (28.85) 67.00 (16.92) 29.50 .008 1.011 .941 
NONACCEPT 12.69 (5.76) 11.42 (6.08) 63.00 ns .214 .855 
GOALS 14.00 (5.71) 10.92 (2.91) 60.00  ns .679 .814 
IMPULSE 14.54 (5.14) 9.33 (3.65) 28.50 .007 1.168 .808 
AWARE 17.54 (5.44) 14.33 (4.27) 44.50 ns .656 .763 
STRATEGIES 18.38 (6.37) 12.92 (4.14) 43.00 ns 1.016 .819 
CLARITY 13.77 (5.08) 8.08 (2.02) 30.50 .008 1.471 .775 
        
BESST 
FACES 
TOTAL 22.85 (7.06) 31.92 (4.33) 16.50 .000 -1.54 .758 
NEUTRAL 4.69 (2.50) 5.42 (1.68) 69.00 ns -.342 .634 
FEAR 2.08 (1.38) 2.58 (2.31) 71.00 ns -.262 .567 
DISGUST 2.38 (1.85) 4.50 (2.27) 34.50 .016 -1.023 .638 
HAPPINESS 7.00 (2.34) 7.92 (1.24) 63.50 ns -.491 .670 
SADNESS 1.08 (1.44) 1.92 (2.23) 62.00 ns -.447 .616 
SURPRISE 2.23 (1.73) 3.58 (1.78) 44.50 ns -.769 .531 
ANGER 3.54 (2.93) 6.00 (2.30) 40.00 .037 -.933 .756 
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Note. BESST TOTAL max score: 70. BESST single emotion max score: 10. Clinical cut-off for the HADS: 8/21. 
AWARE = lack of emotional awareness; CLARITY = lack of emotional clarity; Ctrl = control group; d = Cohen’s 
d effect size; DERS = Difficulties in Emotion Regulation Scale; GOALS = difficulties engaging in goal directed 
behaviour; HADS-A = HADS anxiety score; HADS-D = HADS depression score; HD = symptomatic HD group; 
IMPULSE = impulse control difficulties; NONACCEPT = non-acceptance of emotional responses; SD = standard 
deviation;  STRATEGIES = limited access to emotion regulation strategies; SUM = DERS total score; U = Mann-
Whitney’s U.  
        
BESST 
BODIES 
TOTAL 28.15 (11.08) 39.58 (3.85) 32.00 .012 -1.378 .863 
NEUTRAL 7.00 (3.27) 9.25 (1.29) 40.50 .032 -.905 .896 
FEAR  2.62 (2.47) 5.67 (1.23) 25.00 .004 -1.563 .680 
DISGUST 1.00 (1.29) 1.75 (1.96) 62.50 ns -.452 .638 
HAPPINESS 7.54 (1.39) 7.83 (2.12) 58.00 ns -.156 .627 
SADNESS 4.62 (3.01) 7.58 (1.08) 33.00 .013 -1.309 .815 
SURPRISE 2.62 (1.61) 3.50(1.31) 54.50 ns -.599 .352 
ANGER 2.77 (2.65) 3.92 (2.27) 55.50 ns -.466 .740 
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Table 3 
Spearman's correlation coefficients for the HD group across the variables. 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 
1 
GENDER                               
 
2 
AGE .112                              
 
3 
EDUCATION (YRS) .342 -.127                             
 
4  
DIAGNOSIS  (YRS) -.272 .121 -.073                            
 
5  
TFC SCORE .271 .326 .092 .125                           
 
6  
HD STAGE -.501 -.323 -.325 -.025 -.902**                          
 
7  
HADS_A .022 -.032 -.220 -.204 -.301 .260                         
 
8  
HADS_D -.201 .170 -.135 -.222 -.593* .558* .510                        
 
9 
DERS_SUM .089 .132 -.316 -.168 -.421 .371 .905** .629*                       
 
10 
DERS_NONACCEPT -.067 .029 -.568* -.017 -.441 .484 .739** .404 .878**                      
 
11  
DERS_GOALS .291 -.035 -.218 -.267 -.355 .279 .867** .436 .919** .770**                     
 
12  
DERS_IMPULSE .067 .191 -.396 -.267 -.214 .223 .717** .457 .866** .857** .787**                    
 
13  
DERS_AWARE .134 -.059 .163 -.548 -.453 .334 .383 .825** .437 .124 .358 .265                   
 
14 
DERS_STRATEGIES -.067 .170 -.425 .109 -.550 .558* .765** .632* .916** .861** .823** .724** .301                  
 
15  
DERS_CLARITY -.112 .250 .109 -.371 -.459 .491 .351 .687** .456 .313 .309 .456 .611* .412                 
 
16 
BESST_F_SUM .157 -.213 .296 -.345 .393 -.533 .025 .015 -.168 -.404 -.101 -.082 .287 -.434 -.264                
 
17 
BESST_F_NEUTRAL .383 -.440 .204 -.492 -.080 -.156 -.241 -.211 -.239 -.218 -.156 -.221 .233 -.427 -.299 .377               
 
18 
BESST_F_FEAR .275 -.264 -.157 -.121 .238 -.248 -.259 -.286 -.342 -.312 -.095 -.305 -.184 -.321 -.595* .364 .216              
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 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 
19 
BESST_F_DISGUST .092 -.347 .382 -.216 .408 -.529 .088 -.178 -.179 -.419 -.037 -.159 .105 -.410 -.376 .902** .293 .273             
 
20 
BESST_F_HAPPNSS -.519 -.023 -.249 -.142 .263 -.092 -.257 .018 -.274 -.167 -.421 -.070 -.023 -.357 -.182 .357 .106 .126 .219            
 
21 
BESST_F_SADNESS .310 .131 .248 -.030 -.077 -.040 .079 .590* .115 -.155 .022 -.049 .678* .078 .285 .356 .036 .086 .089 -.143           
 
22 
BESST_F_SUPRISE .271 .197 .375 -.465 -.037 -.207 .254 .338 .206 -.185 .328 .181 .443 .064 .248 .521 .023 .109 .499 -.216 .279          
 
23  
BESST_F_ANGER -.249 -.086 -.029 .136 .099 -.069 .604* .376 .458 .282 .382 .386 .196 .339 -.013 .475 -.359 -.017 .496 .290 .220 .217         
 
24  
BESST_B_SUM .491 -.077 .320 -.238 .521 -.675* -.207 -.259 -.300 -.511 -.080 -.266 .025 -.458 -.546 .739** .357 .700** .691** .204 .215 .456 .212        
 
25 
BESST_B_NEUTRAL .409 -.427 .138 -.111 .223 -.322 -.431 -.549 -.429 -.377 -.179 -.441 -.208 -.456 -.731** .235 .653* .606* .311 .119 -.198 -.100 -.275 .654*       
 
26 
BESST_B_FEAR .551 .261 .309 -.199 .759** -.878** -.298 -.396 -.342 -.499 -.179 -.171 -.167 -.524 -.447 .612* .212 .526 .530 .204 .111 .397 .086 .888** .473      
 
27 
BESST_B_DISGUST .195 -.006 .069 -.266 .287 -.420 .410 .018 .151 -.009 .194 .215 .090 -.089 -.036 .656* .037 .212 .582* -.109 .245 .494 .418 .314 -.251 .340     
 
28 
BESST_B_HAPPNSS -.185 -.327 .081 -.291 -.261 .167 .286 .330 .051 -.190 .103 -.276 .424 .009 -.121 .408 .191 .330 .440 .188 .217 .343 .358 .344 .181 -.006 .210    
 
29 
BESST_B_SADNESS .365 .208 .190 -.083 .496 -.653* -.137 -.044 -.172 -.438 -.051 -.167 .085 -.272 -.466 .713** .156 .567* .628* .203 .335 .568* .317 .910** .424 .835** .337 .328   
 
30 
BESST_B_SURPRISE .578* .036 .747** -.012 .077 -.372 -.069 .165 -.077 -.383 -.011 -.189 .370 -.175 .047 .462 .185 .140 .347 -.332 .718** .499 .154 .509 .096 .448 .303 .119 .507  
 
31 
BESST_B_ANGER .248 -.109 -.055 -.054 .582* -.470 .158 -.127 .089 -.008 .236 .222 -.038 -.064 -.331 .531 -.114 .455 .530 .313 .094 .119 .589* .648* .303 .603* .255 .041 .574* .137 
 
Note. * = p<.05; ** = p<.01; AWARE = lack of emotional awareness; BESST = Bochum Emotional Stimulus Set; BESST_B = BESST Bodies modality; BESST_F = BESST Faces modality; CLARITY = lack of emotional clarity; Ctrl = control 
group; DERS = Difficulties in Emotion Regulation Scale; GOALS = difficulties engaging in goal directed behaviour; HADS = Hospital Anxiety and Depression Scale; HADS-A = HADS anxiety score; HADS-D = HADS depression score; HD 
= Huntington’s disease; IMPULSE = impulse control difficulties; NONACCEPT = non-acceptance of emotional responses; STRATEGIES = limited access to emotion regulation strategies; SUM = total score; TFC = Total Functional 
Capacity; yrs = years.
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Legend to figures 
Figure 1: Example of neutral, positive, and negative emotion stimuli administered via the BESST. On the top are 
stimuli for the face block, on the bottom are stimuli for the body one. The left column shows neutral stimuli; the 
central column shows stimuli for happiness; the right column shows stimuli for fear. Each stimulus was presented 
separately to the participants. 
 
Figure 2: Participants’ results on the emotion recognition tasks. Mean (and standard deviation) of correct 
responses for each of the six-emotion category on the BESST, across both the facial and body language modality 
(max score = 10).  
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